Vimarsana
Biggest News Aggregation in the World

Page 3 - In Process Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from In Process Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In In Process Research Today - Breaking & Trending Today

Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results - Vimarsana News

Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results

$ million Gross to Net Adjustment 19% - 20% 21% - 21.5% Conference Call Puma Biotechnology will host a conference call to report its fourth quarter and full year 2022 financial results... | March 2, 2023

Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update - Vimarsana News

Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update

$9.2M in net product revenue from VTAMA reported for the quarter ended December 31, 2022, with nearly 100,000 VTAMA prescriptions written by approximately 8,600 unique prescribers since launchVTAMA... | February 13, 2023

SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2022 Financial Results - Vimarsana News

SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2022 Financial Results

14.11.2022 - – Cash Position of $21.3 Million as of September 30, 2022 – – Hosting Phase 3 REGAL Study Update Webcast Today at 8:30 a.m. ET – NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) -  SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or ...

Puma Biotechnology Reports Third Quarter 2022 Financial Results - Vimarsana News

Puma Biotechnology Reports Third Quarter 2022 Financial Results

Raises FY 2022 NERLYNX Net Product Revenue GuidanceLOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2022. Unless otherwise stated, all comparisons are for the third quarter of 2022 compared to the...

Roivant Sciences Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March ... - Vimarsana News

Roivant Sciences Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March ...

Potential blockbuster VTAMA® (tapinarof) approved by FDA for the treatment of plaque psoriasis at end of May 2022 is the first topical novel chemical entity launched for plaque psoriasis in